LifeVantage Statistics
Total Valuation
LifeVantage has a market cap or net worth of $80.14 million. The enterprise value is $78.24 million.
| Market Cap | 80.14M |
| Enterprise Value | 78.24M |
Important Dates
The last earnings date was Tuesday, November 4, 2025, after market close.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | Dec 1, 2025 |
Share Statistics
LifeVantage has 12.70 million shares outstanding. The number of shares has increased by 0.80% in one year.
| Current Share Class | 12.70M |
| Shares Outstanding | 12.70M |
| Shares Change (YoY) | +0.80% |
| Shares Change (QoQ) | -1.39% |
| Owned by Insiders (%) | 21.63% |
| Owned by Institutions (%) | 54.86% |
| Float | 8.35M |
Valuation Ratios
The trailing PE ratio is 8.10 and the forward PE ratio is 5.68. LifeVantage's PEG ratio is 0.63.
| PE Ratio | 8.10 |
| Forward PE | 5.68 |
| PS Ratio | 0.34 |
| Forward PS | 0.33 |
| PB Ratio | 2.42 |
| P/TBV Ratio | 2.44 |
| P/FCF Ratio | 9.22 |
| P/OCF Ratio | 7.89 |
| PEG Ratio | 0.63 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.26, with an EV/FCF ratio of 9.00.
| EV / Earnings | 7.72 |
| EV / Sales | 0.34 |
| EV / EBITDA | 5.26 |
| EV / EBIT | 6.58 |
| EV / FCF | 9.00 |
Financial Position
The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.34.
| Current Ratio | 2.39 |
| Quick Ratio | 1.11 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 0.66 |
| Debt / FCF | 1.29 |
| Interest Coverage | 339.91 |
Financial Efficiency
Return on equity (ROE) is 33.31% and return on invested capital (ROIC) is 17.41%.
| Return on Equity (ROE) | 33.31% |
| Return on Assets (ROA) | 12.09% |
| Return on Invested Capital (ROIC) | 17.41% |
| Return on Capital Employed (ROCE) | 27.83% |
| Revenue Per Employee | $961,668 |
| Profits Per Employee | $42,580 |
| Employee Count | 238 |
| Asset Turnover | 3.72 |
| Inventory Turnover | 2.41 |
Taxes
In the past 12 months, LifeVantage has paid $1.77 million in taxes.
| Income Tax | 1.77M |
| Effective Tax Rate | 14.88% |
Stock Price Statistics
The stock price has decreased by -53.47% in the last 52 weeks. The beta is 0.31, so LifeVantage's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | -53.47% |
| 50-Day Moving Average | 8.71 |
| 200-Day Moving Average | 12.63 |
| Relative Strength Index (RSI) | 29.90 |
| Average Volume (20 Days) | 192,480 |
Short Selling Information
The latest short interest is 1.74 million, so 13.68% of the outstanding shares have been sold short.
| Short Interest | 1.74M |
| Short Previous Month | 1.77M |
| Short % of Shares Out | 13.68% |
| Short % of Float | 20.81% |
| Short Ratio (days to cover) | 14.31 |
Income Statement
In the last 12 months, LifeVantage had revenue of $228.88 million and earned $10.13 million in profits. Earnings per share was $0.78.
| Revenue | 228.88M |
| Gross Profit | 183.76M |
| Operating Income | 11.90M |
| Pretax Income | 11.91M |
| Net Income | 10.13M |
| EBITDA | 14.87M |
| EBIT | 11.90M |
| Earnings Per Share (EPS) | $0.78 |
Balance Sheet
The company has $13.09 million in cash and $11.19 million in debt, giving a net cash position of $1.90 million or $0.15 per share.
| Cash & Cash Equivalents | 13.09M |
| Total Debt | 11.19M |
| Net Cash | 1.90M |
| Net Cash Per Share | $0.15 |
| Equity (Book Value) | 33.16M |
| Book Value Per Share | 2.61 |
| Working Capital | 26.22M |
Cash Flow
In the last 12 months, operating cash flow was $10.16 million and capital expenditures -$1.46 million, giving a free cash flow of $8.70 million.
| Operating Cash Flow | 10.16M |
| Capital Expenditures | -1.46M |
| Free Cash Flow | 8.70M |
| FCF Per Share | $0.68 |
Margins
Gross margin is 80.29%, with operating and profit margins of 5.20% and 4.43%.
| Gross Margin | 80.29% |
| Operating Margin | 5.20% |
| Pretax Margin | 5.20% |
| Profit Margin | 4.43% |
| EBITDA Margin | 6.50% |
| EBIT Margin | 5.20% |
| FCF Margin | 3.80% |
Dividends & Yields
This stock pays an annual dividend of $0.18, which amounts to a dividend yield of 2.85%.
| Dividend Per Share | $0.18 |
| Dividend Yield | 2.85% |
| Dividend Growth (YoY) | 12.90% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 22.45% |
| Buyback Yield | -0.80% |
| Shareholder Yield | 2.06% |
| Earnings Yield | 12.64% |
| FCF Yield | 10.85% |
Analyst Forecast
The average price target for LifeVantage is $30.50, which is 383.36% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $30.50 |
| Price Target Difference | 383.36% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 19, 2015. It was a reverse split with a ratio of 1:7.
| Last Split Date | Oct 19, 2015 |
| Split Type | Reverse |
| Split Ratio | 1:7 |
Scores
LifeVantage has an Altman Z-Score of 6.37 and a Piotroski F-Score of 7.
| Altman Z-Score | 6.37 |
| Piotroski F-Score | 7 |